Skip to main content
IIPR
NYSE Real Estate & Construction

IIPR Q2 2026: AFFO Reaches $1.83, Liquidity Hits $300M, IQHQ Fully Funded, and Tenant Resolutions Advance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: REIT Stocks · Real Estate
Sentiment info
Positive
Importance info
8
Price
$58.59
Mkt Cap
$1.699B
52W Low
$44.58
52W High
$65.38
52W Position info
31% above low
Off High info
10% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

IIPR sits 31% above its 52-week low of $44.58.

Summary

IIPR reported Q2 2026 AFFO of $1.83 per share, fully funded its $270M IQHQ investment, resolved PharmaCann litigation, and advanced re-tenanting of 4Front assets. With $300M in liquidity and low leverage, the company has moved past its near-term debt wall and tenant defaults.


Key Events · Earnings and Guidance · IIPR

  • Q2 AFFO $1.83, Revenue $63.3M

    AFFO per share of $1.83 beat the $1.71 consensus estimate; total revenues were $63.3M, up 0.7% year-over-year, driven by new leasing and contractual rent escalations.

  • IQHQ Investment Fully Funded

    The $270M strategic life science investment ( $100M revolver at 13.5% yield, $170M preferred equity at 15.0% yield ) was fully funded in Q2, diversifying income beyond cannabis.

  • Tenant Defaults Resolved or Advancing

    PharmaCann litigation settled with monetary judgments; Ohio property re-leased to Curaleaf. 4Front assets have tentative new tenants, with transitions expected by early 2027.

  • Balance Sheet Transformed

    Liquidity stands at $299.7M; net debt to adjusted EBITDA is 1.7x; the $291M 2026 notes were fully repaid; $402.5M exchangeable notes issued at 6.00%.


Analysis · IIPR · Real Estate & Construction

A solid quarter saw Innovative Industrial Properties deliver AFFO of $1.83 per share, fully fund its $270M IQHQ life science investment, and make tangible progress resolving troubled tenant situations. The balance sheet is in its strongest position in over a year — $300M in liquidity, net leverage at just 1.7x, and the $291M 2026 note maturity fully repaid. The PharmaCann settlement and 4Front re-tenanting plans reduce a major overhang, while the $402.5M exchangeable notes raise and ATM equity issuances demonstrate capital markets access despite prior going-concern concerns. The dividend remains covered on an AFFO basis (104% payout ratio), and the portfolio is 96% leased. This quarter marks a turning point from survival to offense.

At the time of this filing, IIPR was trading at $58.59 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $44.58 to $65.38. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IIPR - Latest Insights

IIPR
Jul 21, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $64.00
Real-time Price: $58.59 info
Change: -$5.41 (-8%) info
Market Cap: $1.699B info
IIPR
Jun 16, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $60.50
Real-time Price: $58.59 info
Change: -$1.91 (-3%) info
Market Cap: $1.699B info
IIPR
Jun 15, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $60.50
Real-time Price: $58.59 info
Change: -$1.91 (-3%) info
Market Cap: $1.699B info
IIPR
Jun 11, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $61.77
Real-time Price: $58.59 info
Change: -$3.18 (-5%) info
Market Cap: $1.699B info
IIPR
Jun 09, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $57.96
Real-time Price: $58.59 info
Change: +$0.630 (+1%) info
Market Cap: $1.699B info